Rational drug design approach for overcoming drug resistance: Application to pyrimethamine resistance in malaria
Pyrimethamine acts by selectively inhibiting malarial dihydrofolate reductase-thymidylate synthase (DHFR-TS). Resistance in the most important human parasite, Plasmodium falciparum, initially results from an S108N mutation in the DHFR domain, with additional mutation (most commonly C59R or N51I or b...
Saved in:
Main Authors: | James H. McKie, Kenneth T. Douglas, Cecil Chan, Simon A. Roser, Robert Yates, Martin Read, John E. Hyde, Michael J. Dascombe, Yongyuth Yuthavong, Worachart Sirawaraporn |
---|---|
Other Authors: | University of Manchester |
Format: | Article |
Published: |
2018
|
Subjects: | |
Online Access: | https://repository.li.mahidol.ac.th/handle/123456789/18305 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Institution: | Mahidol University |
Similar Items
-
Kinetic and molecular properties of dihydrofolate reductase from pyrimethamine-sensitive and pyrimethamine-resistant Plasmodium chabaudi
by: Worachart Sirawaraporn, et al.
Published: (2018) -
Pyrimethamine analogue inhibitors of resistance mutants of Plasmodial dihydrofolate reductase
by: Ali Sardarian, et al.
Published: (2018) -
Potentiating effect of pyrimethamine and sulfadoxine against dihydrofolate reductase from pyrimethamine-sensitive and pyrimethamine-resistant Plasmodium chabaudi
by: W. Sirawaraporn, et al.
Published: (2018) -
Overcoming drug resistance by co-targeting
by: Ayati, M., et al.
Published: (2013) -
Interaction of pyrimethamine, cycloguanil, WR99210 and their analogues with Plasmodium falciparum dihydrofolate reductase: Structural basis of antifolate resistance
by: Giulio Rastelli, et al.
Published: (2018)